Lycera Announces Research Collaboration with MerckThe Plymouth-based biopharmaceutical developer Lycera Corp. Thursday announced an exclusive research collaboration with pharma giant Merck to develop drug candidates that have the potential to treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen